CAH vs ORMP
Cardinal Health Inc (CAH) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
Cardinal Health Inc (CAH) is a medical distribution company listed on NYSE.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported CAH revenue for 2025-06-30 was $222.58B. Net income was $1.57B. Revenue was down 1.9% from 2024-06-30 to 2025-06-30. CAH currently screens at market cap $53.00B and trailing P/E 34.6.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
CAH currently screens at market cap $53.00B and trailing P/E 34.6. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the CAH and ORMP stock pages for the full models.
Not investment advice.